Paper17513564
Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae.
Lamping E and 8 others. Eukaryot Cell, 2007. Cited by 159 papers, by iCite.
Cite this record
ConductScience Library. Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Papers, record 17513564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17513564
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Azoles | Major topic |
| Drug Resistance, Fungal | Major topic |
| Gene Expression Regulation, Fungal | Major topic |
| Membrane Proteins | Major topic |
| Saccharomyces cerevisiae | Major topic |
| Saccharomyces cerevisiae Proteins | Major topic |
| ATP Binding Cassette Transporter, Subfamily B | |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| ATP-Binding Cassette Transporters | |
| Antinematodal Agents | |
| Humans | |
| Macrolides | |
| Open Reading Frames | |
| Plasmids | |
| Recombinant Fusion Proteins | |
| Substrate Specificity |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DE016885 | NIDCR NIH HHS | United States | R01DE016885 | PubMed and NIH | NIH RePORTER |
| R01DE016885-01-RDC | NIDCR NIH HHS | United States | R01DE016885 | PubMed and NIH | NIH RePORTER |
| R21DE015075-RDC | NIDCR NIH HHS | United States | R21DE015075 | PubMed and NIH | NIH RePORTER |
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17185560 | A "silent" polymorphism in the MDR1 gene changes substrate specificity. | Science | 2007 | https://conductscience.org/library/papers/17185560 | PubMed |
| 2 | 15529166 | Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. | Nat Biotechnol | 2004 | https://conductscience.org/library/papers/15529166 | PubMed |
| 3 | 15229592 | Genome evolution in yeasts. | Nature | 2004 | https://conductscience.org/library/papers/15229592 | PubMed |
| 4 | 16942600 | Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2. | Mol Microbiol | 2006 | https://conductscience.org/library/papers/16942600 | PubMed |
| 5 | 15498768 | Phosphorylation of candida glabrata ATP-binding cassette transporter Cdr1p regulates drug efflux activity and ATPase stability. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15498768 | PubMed |
| 6 | 13678421 | Structure and function of efflux pumps that confer resistance to drugs. | Biochem J | 2003 | https://conductscience.org/library/papers/13678421 | PubMed |
| 7 | 10716173 | A novel method of affinity-purifying proteins using a bis-arsenical fluorescein. | Protein Sci | 2000 | https://conductscience.org/library/papers/10716173 | PubMed |
| 8 | 8031026 | Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8031026 | PubMed |
| 9 | 11709310 | Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11709310 | PubMed |
| 10 | 10734226 | Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants. | FEBS Lett | 2000 | https://conductscience.org/library/papers/10734226 | PubMed |
| 11 | 11347972 | Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. | Farmaco | 2001 | https://conductscience.org/library/papers/11347972 | PubMed |
| 12 | 15728981 | Functional analysis of fungal drug efflux transporters by heterologous expression in Saccharomyces cerevisiae. | Jpn J Infect Dis | 2005 | https://conductscience.org/library/papers/15728981 | PubMed |
| 13 | 10994811 | New milbemycins from Streptomyces hygroscopicus subsp. aureolacrimosus: fermantation, isolation and strucutre elucidation. | J Antibiot (Tokyo) | 2000 | https://conductscience.org/library/papers/10994811 | PubMed |
| 14 | 16847257 | Phenotypic effects of membrane protein overexpression in Saccharomyces cerevisiae. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16847257 | PubMed |
| 15 | 17352537 | Function-altering SNPs in the human multidrug transporter gene ABCB1 identified using a Saccharomyces-based assay. | PLoS Genet | 2007 | https://conductscience.org/library/papers/17352537 | PubMed |
| 16 | 12244114 | Candida glabrata ATP-binding cassette transporters Cdr1p and Pdh1p expressed in a Saccharomyces cerevisiae strain deficient in membrane transporters show phosphorylation-dependent pumping properties. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12244114 | PubMed |
| 17 | 11931723 | ATP-binding cassette (ABC) transporters in atherosclerosis. | Curr Atheroscler Rep | 2002 | https://conductscience.org/library/papers/11931723 | PubMed |
| 18 | 11421285 | Fungal ABC proteins: pleiotropic drug resistance, stress response and cellular detoxification. | Res Microbiol | 2001 | https://conductscience.org/library/papers/11421285 | PubMed |
| 19 | 15707993 | Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae. | Biochem Biophys Res Commun | 2005 | https://conductscience.org/library/papers/15707993 | PubMed |
| 20 | 11938023 | Sulfonylurea receptor -1 (SUR1): genetic and metabolic evidences for a role in the susceptibility to type 2 diabetes mellitus. | Diabetes Metab | 2002 | https://conductscience.org/library/papers/11938023 | PubMed |
Cited by98
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 159 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42897333 | ATP-driven dynamics and itraconazole binding of the drug efflux pump Cdr1 from Candida glabrata. | EMBO J | 2026 | https://conductscience.org/library/papers/42897333 | PubMed |
| 42857173 | ER stress selects for Candida auris survivors with acquired fluconazole resistance and caspofungin tolerance. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42857173 | PubMed |
| 42182027 | Functional characterization of Candida auris DHA1 transporters conferring flucytosine resistance. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42182027 | PubMed |
| 41744681 | G521 is the gatekeeper and a key transmembrane domain contact residue of Candida albicans Cdr1. | mBio | 2026 | https://conductscience.org/library/papers/41744681 | PubMed |
| 41450950 | Use of gain-of-function suppressor screening to elucidate Candida albicans Cdr1 efflux mechanism, inhibition, and drug resistance. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41450950 | PubMed |
| 41383730 | Intrinsic resistance to short-tailed azoles in the basal fungus Mucor lusitanicus: functional analysis of Cyp51 isoforms and amino acid substitutions. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41383730 | PubMed |
| 41347522 | The molecular basis of intrinsic resistance to azoles in Rhizopus arrhizus. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/41347522 | PubMed |
| 41025309 | Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus. | J Antimicrob Chemother | 2025 | https://conductscience.org/library/papers/41025309 | PubMed |
| 40101948 | Functional analysis of Candida albicans Cdr1 through homologous and heterologous expression studies. | FEMS Yeast Res | 2025 | https://conductscience.org/library/papers/40101948 | PubMed |
| 39728316 | The Molecular Basis of the Intrinsic and Acquired Resistance to Azole Antifungals in Aspergillus fumigatus. | J Fungi (Basel) | 2024 | https://conductscience.org/library/papers/39728316 | PubMed |
| 39590782 | Batzelladine D, a Marine Natural Product, Reverses the Fluconazole Resistance Phenotype Mediated by Transmembrane Transporters in Candida albicans and Interferes with Its Biofilm: An In Vitro and In Silico Study. | Mar Drugs | 2024 | https://conductscience.org/library/papers/39590782 | PubMed |
| 39312388 | An in vitro set-up to study Pdr5-mediated substrate translocation. | Protein Sci | 2024 | https://conductscience.org/library/papers/39312388 | PubMed |
| 38813525 | Effects of efflux pumps on antifungal activity of chitosan against Candida albicans. | J Oral Microbiol | 2024 | https://conductscience.org/library/papers/38813525 | PubMed |
| 37504746 | Synthesis of Altissimacoumarin D and Other Prenylated Coumarins and Their Ability to Reverse the Multidrug Resistance Phenotype in Candida albicans. | J Fungi (Basel) | 2023 | https://conductscience.org/library/papers/37504746 | PubMed |
| 37367600 | Clorgyline Analogs Synergize with Azoles against Drug Efflux in Candida auris. | J Fungi (Basel) | 2023 | https://conductscience.org/library/papers/37367600 | PubMed |
| 36836283 | Functional Expression of Recombinant Candida auris Proteins in Saccharomyces cerevisiae Enables Azole Susceptibility Evaluation and Drug Discovery. | J Fungi (Basel) | 2023 | https://conductscience.org/library/papers/36836283 | PubMed |
| 36547589 | Exploring Cryptococcus neoformans CYP51 and Its Cognate Reductase as a Drug Target. | J Fungi (Basel) | 2022 | https://conductscience.org/library/papers/36547589 | PubMed |
| 36277891 | Molecular Mechanisms of Antifungal Resistance in Mucormycosis. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/36277891 | PubMed |
| 36224581 | Extracts from Argentinian native plants reverse fluconazole resistance in Candida species by inhibiting the efflux transporters Mdr1 and Cdr1. | BMC Complement Med Ther | 2022 | https://conductscience.org/library/papers/36224581 | PubMed |
| 36184687 | Genomic landscape of the DHA1 family in Candida auris and mapping substrate repertoire of CauMdr1. | Appl Microbiol Biotechnol | 2022 | https://conductscience.org/library/papers/36184687 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17513564
GET https://conductscience.org/api/papers/v1/17513564/references?page=2